Crowdonomics
WatchlistPortfolio
NanoMed Tracking, Inc.

Reg CF · Common Stock · Aug 2021

ClosedReg CFCommon Equity
via NetcapitalView campaign
Raised
$0 / $107K max
0% of ceiling
Investors
—
—
Post-money valuation
$4M
pre-money + amount raised

Raised over time

Cumulative raised
$3K$2K$0
Aug 6, 2021 · openedOct 4, 2021 · last reading
Deadline Dec 10, 2021 — 67 days out

Left axis: cumulative dollars raised. Live figures via Netcapital; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$0
FY2019
$0
FY2020
RevenueNet income
Metric
FY2019 unaudited
FY2020 unaudited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
3

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Oct 5, 2021
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$4M
Post-money$4M
Price / share$0.41
Shares offered24,391

Offering details

Target$10,000
Max$107,000
Min investment$99
OpenedAug 6, 2021
DeadlineDec 10, 2021
ClosedOct 4, 2021
Days active59

Links & provenance

Campaign pageSEC filing
Source: Manual
0001669191-21-000762

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.